To date, four Clinical Practice Guidelines (CPGs) have been published and five other guidelines have been approved by The Endocrine Society’s Council. There are currently eight other CPGs in various stages of development.

Guidelines Approved by Council & Published:

• Growth Hormone Treatment in Adults – Mark Molitch, MD, Chair
• Androgen Deficiency in Men – Shalender Bhasin, MD, Chair
• Androgen Therapy in Women – Margaret Wierman, MD, Chair
• Management of Thyroid Dysfunction during Pregnancy & Postpartum – Leslie DeGroot, MD, Chair

Guidelines Approved by Council & Recently Accepted for Publishing in JCEM:

• Evaluation and Treatment of Hirsutism in Premenopausal Women – Kathryn Martin, MD, Chair
• The Diagnosis of Cushing’s Syndrome – Lynnette Nieman, MD, Chair

Guidelines Approved by Council & Undergoing JCEM Peer Review:

• Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk - James Rosenzweig, MD, Chair
• Prevention & Treatment of Pediatric Obesity – Gilbert August, MD, Chair
• Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism – John Funder, MD, Chair

Guideline Undergoing Member and Co-sponsor Review:

• Evaluation and Management of Adult Hypoglycemic Disorders – Philip Cryer, MD, Chair. If you are a full member of The Endocrine Society, please visit this site to submit your comments.

Guidelines in Progress:

• Congenital Adrenal Hyperplasia – Phyllis Speiser, MD, Chair 
• Continuous Glucose Monitoring – David C. Klonoff, MD, FACP, Chair
• Endocrine Treatment of Transsexuals – Wylie Hembree, MD, Chair
• Lipids - TBD · Post Bariatric Surgery – Caroline Apovian, MD, Chair
• Pituitary Incidentaloma – Pamela Freda, MD, Chair
• Vitamin D & Bone – Mike Holick, MD, Chair

Each guideline is created by a task force whose membership consists of experts in the field. These task forces rely on evidence-based reviews of the literature to provide support for the recommendations. The Society has contracted with the Knowledge and Encounter Research Unit of the Mayo Clinic College of Medicine, which uses the GRADE scheme for evidence review. This system takes into account relative strengths and weaknesses of the best available evidence. The GRADE scheme was recognized in ACP Journal Club as a state of the art approach that is “rigorous in its methodology, yet practical to use.” The Society is the first North American organization to adopt the GRADE approach for its guidelines.

Although the CPG’s are not available for support, The Endocrine Society is currently working with Anatstat USA Health Education Media to develop enduring products to the Society’s Clinical Practice Guidelines. These enduring products are available for sponsorship and will serve to increase awareness and potential usage of the guidelines and include items such as wall board and pocket guides for physicians.

The Hormone Foundation also develops patient companion pieces to complement each CPG. These guides are designed to help patients with specific endocrine-disorders to partner with their physicians to reach their treatment goals. Upcoming patient guides include: “Cushing’s Syndrome” which will be published in May and “The Metabolic Syndrome” which will be published in late summer or early fall. The Hormone Foundation patient guides are available for sponsorship and offer a unique opportunity for public exposure through patient education efforts.

Please contact Teresa Favero at 301-941-0229 or tfavero@endo-society.org for more information on supporting guideline enduring materials or patient companion pieces.